By Ben Glickman
Workday said customers had put greater scrutiny on subscriptions in the fiscal first quarter and the company saw weaker-than-anticipated headcount growth among customers. The HR-software company slashed its full-year guidance for subscription revenue. Shares fell 11%, to $232, post-market.
Deckers Outdoor's sales rose 21% and handily beat Wall Street expectations, buoyed by strong growth in sales of Hoka-brand shoes. The company's profit rose in the fiscal fourth quarter and also topped estimates. Shares rose 8.1%, to $977.70, in after-hours trading.
Verastem said that its trial evaluating a combination of therapies to treat pancreatic cancer found a high overall response rate in one cohort. The company said that the vast majority of patients in all dosing cohorts who had scans taken experienced a reduction of the change in target lesion sum of diameters. Shares shot up 52%, to $18.57, in extended trading.
Write to Ben Glickman at ben.glickman@wsj.com
(END) Dow Jones Newswires
May 23, 2024 19:47 ET (23:47 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments